Grant Simons, MD
Clinical Cardiac Electrophysiology · Englewood, NJNPI 1568532927
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Novartis at 40.6% of the total. 2025 is the largest year on record at $43,616, 3.9 times the $11,267 reported in 2019. Among clinical cardiac electrophysiology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $408.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$38K
- Abbott$36K
- E.r. Squibb & Sons, L.L.C.$8K
- Boston Scientific$5K
- Medtronic$4K
- Abiomed$395
- plus $1K from 22 others
Across 56 payments — averaging $1779.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$53K
- Abbott$25K
- Atricure, Inc.$11K
- Medtronic$11K
What the payments were for
- Consulting fees$54,91859%
- Speaking & faculty fees$16,02517%
- Travel & lodging$11,67712%
- Food & beverage$8,1569%
- Other$2,7103%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 28 | $37,909 |
| Abbott | 66 | $35,923 |
| E.r. Squibb & Sons, L.L.C. | 12 | $8,089 |
| Boston Scientific | 30 | $5,203 |
| Medtronic(2 entities) | 30 | $4,495 |
| Abiomed | 9 | $395 |
| Atricure, Inc. | 4 | $232 |
| W. L. Gore & Associates, Inc. | 2 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $184 |
| Amgen | 2 | $131 |
| Biosense Webster, Inc. | 5 | $119 |
| Penumbra, Inc. | 1 | $100 |
| Cordis US CORP. | 6 | $98 |
| AstraZeneca | 6 | $73 |
| Cardiva Medical, Inc. | 3 | $57 |
| Biotronik Inc. | 2 | $36 |
| Irhythm Technologies, Inc. | 1 | $35 |
| Johnson & Johnson(2 entities) | 2 | $31 |
| Pfizer | 2 | $29 |
| Philips North America LLC | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 2 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
| GE HealthCare | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $17 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Preventice Services, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISQALI$37,865
- AMPLATZER AMULET$32,589
- ELIQUIS$7,890
- Watchman$3,841
- Arctic Front$2,224
- AVEIR$1,819
- WATCHMAN FLX$535
- Micra$314
- COBALT DR MRI SURESCAN$287
- WATCHMAN Access System$287
- Impella$210
- CareLink$200
- GORE CARDIOFORM Septal Occluder$175
- Reveal LINQ$168
- SureScan$166
- AURORA EV-ICD MRI SURESCAN$164
- AMPLATZER Occluders$146
- Optis Coronary Imaging System$142
- Amplia MRI$138
- AZURE XT DR MRI SURESCAN$127
How this compares
$93,485 in reported general payments places this provider in the 90th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $84,301 |
| MultaqDronedarone Hcl | 39 | $58,617 |
| XareltoRivaroxaban | 20 | $21,525 |
| Amiodarone Hcl | 57 | $1,498 |
| Metoprolol Succinate | 55 | $882 |
| Dofetilide | 13 | $864 |
| ClopidogrelClopidogrel Bisulfate | 17 | $209 |
| Amlodipine Besylate | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $29 | $84,30171 claims |
| Johnson & JohnsonXarelto | $31 | $21,52520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Englewood
- Dmitry NemirovskyEnglewood$37K
- Benjamin D SouzaCherry Hill$741K
- Suneet MittalParamus$722K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.